THE ROLE OF THE MATRIX METALLOPROTEINASES IN THE DEVELOPMENT OF LEFT VENTRICULAR HYPERTROPHY IN PATIENTS WITH ARTERIAL HYPERTENSION AND METABOLIC SYNDROME
Aim. To assess the role of the activation of matrix metalloproteinase-1 zymogen (ProMMP-1) and tissue inhibitor of metalloproteinase-1 (TIMP-1) in the development of left ventricular (LV) hypertrophy in patients with arterial hypertension (HT) and metabolic syndrome (MS) with varying degree of obesi...
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Столичная издательская компания
2015-09-01
|
| Col·lecció: | Рациональная фармакотерапия в кардиологии |
| Matèries: | |
| Accés en línia: | https://www.rpcardio.online/jour/article/view/135 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|